Oxford Nanopore Technologies (LON:ONT – Get Free Report) was downgraded by equities research analysts at Citigroup to a “buy” rating in a report released on Monday,Digital Look reports.
Several other equities research analysts have also weighed in on the stock. Royal Bank Of Canada reiterated an “outperform” rating and set a GBX 225 price objective on shares of Oxford Nanopore Technologies in a research note on Tuesday, May 26th. Peel Hunt restated a “hold” rating and issued a GBX 153 target price on shares of Oxford Nanopore Technologies in a research note on Monday, July 13th. Finally, Berenberg Bank lowered their target price on Oxford Nanopore Technologies from GBX 230 to GBX 220 and set a “buy” rating for the company in a report on Monday, July 13th. Four research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat.com, Oxford Nanopore Technologies currently has an average rating of “Moderate Buy” and an average target price of GBX 212.60.
View Our Latest Stock Analysis on Oxford Nanopore Technologies
Oxford Nanopore Technologies Trading Up 0.6%
Insider Activity at Oxford Nanopore Technologies
In other news, insider Nick Keher purchased 22,018 shares of the stock in a transaction dated Monday, May 11th. The stock was acquired at an average price of GBX 113 per share, for a total transaction of £24,880.34. Insiders have bought a total of 22,774 shares of company stock worth $2,578,100 in the last three months. 2.54% of the stock is currently owned by corporate insiders.
About Oxford Nanopore Technologies
Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.
See Also
- Five stocks we like better than Oxford Nanopore Technologies
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
